NCT02573077View on ClinicalTrials.gov

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 13, 2017

Study Completion Date

December 13, 2017

Conditions
HyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionCancer
Trial Locations (20)

Unknown

Ancona

Aosta

Bari

Cagliari

Cosenza

Florence

Genova

Messina

Milan

Napoli

Negrar

Novara

Palermo

Parma

Perugia

Piacenza

Pisa

Roma

Varese

Verona

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Europe Ltd

INDUSTRY

NCT02573077 - An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy | Biotech Hunter | Biotech Hunter